He Closed a Wound, Which Exposed a New One.

A doctor closed a wound nobody else could close, and he still has the patient to prove it. This week, he told me that if he could go back, he would never have touched the case.

I hear versions of that sentence often. I work alongside physicians navigating advanced wound care, and lately, in exam rooms that once took on the toughest referrals without hesitation, I keep hearing the same conclusion: "I can't go through that again," or more bluntly, "I won't."

When the Review Lasts Longer Than the Treatment

After he healed his patients, CMS (the Centers for Medicare & Medicaid Services) reviewed his work.

Every note he wrote to document that care became part of the review. The wounds had closed, and the records proved it. But by the time the review began, the question was no longer whether the patient healed. It was whether each decision could be defended under standards interpreted years after the care was delivered.

That is what gets missed about audit exposure in this field. Physicians who take on the sickest wounds also generate the most complete clinical records, and those records become the foundation of any review. Regardless of outcome, the review itself carries a cost. Appeals move at their own pace, and the practice keeps paying staff, rent, and legal fees while it waits.

This doctor came through it with his license, his patients, and his practice intact. He also came away certain he would never make those same decisions again.

The Variable That Doesn't Show Up on a Fee Schedule

Everyone serving this market watches the rate. We tell ourselves a higher ASP (average sales price, the reimbursement benchmark tied to a product's billing code) will bring physicians back to difficult cases.

It won't, not on its own. What actually decides whether a physician takes the next hard referral is confidence, not economics. A better rate doesn't undo years spent defending care that was clinically sound, and that calculation runs long before a chart is ever opened.

Two years ago, this doctor took a difficult case without a second thought. Now he counts first.

Patients never see that calculation. There is no line in the chart for the review that changed how their physician thinks. They arrive needing a wound closed, and they meet a physician weighing the clinical need against the exposure that comes with treating it.

The downStream impacts

Referrals slow. Difficult cases get passed from one practice to the next. Some physicians decide the exposure outweighs the reward. Every additional handoff costs time that a difficult wound often cannot spare.

These are the costs nobody prices. The physician absorbs the review, patients absorb the hesitation. Neither shows up in the number the industry keeps refreshing.

Raising reimbursement alone will not restore the confidence that prolonged reviews have destroyed. Keeping experienced physicians in the hardest cases takes consistent documentation standards, predictable review processes, and the assurance that years spent treating patients will not turn into years spent defending that treatment.

Bionavix exists to close that gap. We help practices interpret coverage behavior, strengthen documentation before treatment begins, align product selection with defensible clinical decisions, and stay engaged through the case, not just at the start of it. If you are weighing whether to take on a difficult referral, or want to know whether your current documentation would hold up under review, call us. We'll walk through it with you before the case ever reaches CMS.